Money · Lobbying reports · 119th Congress
S. 864
36 saved lobbying reports name S. 864.
36 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 6:14 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000.00reported as expenses | April to June 2026 | Open the report |
| ARTHRITIS FOUNDATION | ARTHRITIS FOUNDATION | $75,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN ACADEMY OF OPHTHALMOLOGY | AMERICAN ACADEMY OF OPHTHALMOLOGY | $302,068.00reported as expenses | April to June 2026 | Open the report |
| VERTEX PHARMACEUTICALS INCORPORATED | VERTEX PHARMACEUTICALS INCORPORATED | $1,200,000.00reported as expenses | April to June 2026 | Open the report |
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | $480,000.00reported as expenses | April to June 2026 | Open the report |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $890,000.00reported as expenses | April to June 2026 | Open the report |
| THE NICKLES GROUP, LLC | UCB, INC. | $70,000.00reported as income | April to June 2026 | Open the report |
| EMERGENT STRATEGIES | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $60,000.00reported as income | April to June 2026 | Open the report |
| SPANGLER STRATEGIES LLC | AMERICAN BANKERS ASSOCIATION | $20,000.00reported as income | April to June 2026 | Open the report |
| UCB, INC. | UCB, INC. | $710,000.00reported as expenses | April to June 2026 | Open the report |
| THE KPM GROUP DC LLC | THE HS COALITION | $50,000.00reported as income | April to June 2026 | Open the report |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. | AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | $1,240,000.00reported as expenses | April to June 2026 | Open the report |
| ARTEMIS POLICY GROUP LLC | THE HEMOPHILIA ALLIANCE | $30,000.00reported as income | April to June 2026 | Open the report |
| ARTEMIS POLICY GROUP LLC | NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) | $50,000.00reported as income | April to June 2026 | Open the report |
| NOVARTIS | NOVARTIS | $1,410,000.00reported as expenses | April to June 2026 | Open the report |
| THE ALS ASSOCIATION | THE ALS ASSOCIATION | $30,000.00reported as expenses | April to June 2026 | Open the report |
| WILLIAMS AND JENSEN, PLLC | ABBVIE, INC. | $30,000.00reported as income | April to June 2026 | Open the report |
| WILLIAMS AND JENSEN, PLLC | BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.) | $80,000.00reported as income | April to June 2026 | Open the report |
| WILLIAMS AND JENSEN, PLLC | BRISTOL-MYERS SQUIBB COMPANY | $80,000.00reported as income | April to June 2026 | Open the report |
| ALLIANCE FOR PATIENT ACCESS | ALLIANCE FOR PATIENT ACCESS | $20,000.00reported as expenses | April to June 2026 | Open the report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,360,000.00reported as expenses | April to June 2026 | Open the report |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $1,440,000.00reported as expenses | April to June 2026 | Open the report |
| ABBVIE, INC. | ABBVIE INC. | $1,160,000.00reported as expenses | April to June 2026 | Open the report |
| CYSTIC FIBROSIS FOUNDATION | CYSTIC FIBROSIS FOUNDATION | $270,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $3,010,000.00reported as expenses | April to June 2026 | Open the report |
| TODD STRATEGY GROUP | ASTRAZENECA PHARMACEUTICALS LP | $80,000.00reported as income | April to June 2026 | Open the report |
| AMERICAN COLLEGE OF RHEUMATOLOGY | AMERICAN COLLEGE OF RHEUMATOLOGY | $180,000.00reported as expenses | April to June 2026 | Open the report |
| VENABLE LLP | PATIENT ACCESS NETWORK FOUNDATION | $40,000.00reported as income | April to June 2026 | Open the report |
| BIOGEN | BIOGEN | $1,060,000.00reported as expenses | April to June 2026 | Open the report |
| TODD STRATEGY GROUP | EMD SERONO INC. | $50,000.00reported as income | April to June 2026 | Open the report |
| TODD STRATEGY GROUP | JOHNSON & JOHNSON SERVICES, INC. | $100,000.00reported as income | April to June 2026 | Open the report |
| TODD STRATEGY GROUP | MERCK & CO., INC. | $50,000.00reported as income | April to June 2026 | Open the report |
| TODD STRATEGY GROUP | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $80,000.00reported as income | April to June 2026 | Open the report |
| EMD SERONO, INC. | EMD SERONO INC | $700,000.00reported as expenses | April to June 2026 | Open the report |
| SANOFI US SERVICES INC. | SANOFI US SERVICES INC | $920,000.00reported as expenses | April to June 2026 | Open the report |
| THE KPM GROUP DC LLC | SOLENO THERAPEUTICS, INC. | $10,000.00reported as income | April to June 2026 | Open the report |